Email Alerts
RSS
Volume 39 Issue 9
Sep.  2023
Turn off MathJax
Article Contents
Article Navigation >  CHINESE JOURNAL OF BURNS AND WOUNDS  > 2023  >  39(9): 886-890
Su YH,Xia WZ,Huang X,et al.Research advances in the treatment of keloid with glucocorticoids[J].Chin J Burns Wounds,2023,39(9):886-890.DOI: 10.3760/cma.j.cn501225-20230602-00198.
Citation: Su YH,Xia WZ,Huang X,et al.Research advances in the treatment of keloid with glucocorticoids[J].Chin J Burns Wounds,2023,39(9):886-890.DOI: 10.3760/cma.j.cn501225-20230602-00198.
shu

Research advances in the treatment of keloid with glucocorticoids

doi: 10.3760/cma.j.cn501225-20230602-00198

  • Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China

Funds:

General Program of National Natural Science Foundation of China 82272264, 82072177

Shanghai Clinical Research Center of Plastic and Reconstructive Surgery Supported by Science and Technology Commission of Shanghai Municipality 22MC1940300

More Information
    Abstract
  • As a first-line classical drug, glucocorticoids are used in most combination treatment regimens of keloid. However, there are issues such as poor treatment efficacy and recurrence of keloid after keloid was treated with glucocorticoids, which seriously affect the therapeutic effect. In recent years, many studies have explored the factors influencing the efficacy of glucocorticoids in treating keloid and the action mechanism of glucocorticoids from different perspectives. Based on this, this paper reviews the mechanism and the factors influencing the efficacy of glucocorticoids in treating keloid, and explores ways to improve the treatment efficacy of glucocorticoids, aiming to provide thoughts for improving glucocorticoid-related diagnostic and therapeutic strategies.

     

    • FullText(HTML)
  • loading
    • References(38)
  • [1]
    中国整形美容协会瘢痕医学分会常务委员会专家组.中国瘢痕疙瘩临床治疗推荐指南[J].中国美容整形外科杂志,2018,29(5):前插3-前插14.DOI: 10.3969/j.issn.1673-7040.2018.05.001.
    [2]
    OgawaR.The most current algorithms for the treatment and prevention of hypertrophic scars and keloids: a 2020 update of the algorithms published 10 years ago[J].Plast Reconstr Surg,2022,149(1):79e-94e.DOI: 10.1097/PRS.0000000000008667.
    [3]
    LeeHJ,JangYJ.Recent understandings of biology, prophylaxis and treatment strategies for hypertrophic scars and keloids[J].Int J Mol Sci,2018,19(3):711.DOI: 10.3390/ijms19030711.
    [4]
    SchmidtS,RainerJ,PlonerC,et al.Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance[J].Cell Death Differ,2004,11 Suppl 1:S45-55.DOI: 10.1038/sj.cdd.4401456.
    [5]
    ShengM,ChenY,LiH,et al.The application of corticosteroids for pathological scar prevention and treatment: current review and update[J/OL].Burns Trauma,2023,11:tkad009[2023-06-02].https://pubmed.ncbi.nlm.nih.gov/36950503/.DOI: 10.1093/burnst/tkad009.
    [6]
    ShimbaA,IkutaK.Control of immunity by glucocorticoids in health and disease[J].Semin Immunopathol,2020,42(6):669-680.DOI: 10.1007/s00281-020-00827-8.
    [7]
    WuWS,WangFS,YangKD,et al.Dexamethasone induction of keloid regression through effective suppression of VEGF expression and keloid fibroblast proliferation[J].J Invest Dermatol,2006,126(6):1264-1271.DOI: 10.1038/sj.jid.5700274.
    [8]
    WangQ,ZhongY,LiZ,et al.Multitranscriptome analyses of keloid fibroblasts reveal the role of the HIF-1α/HOXC6/ERK axis in keloid development[J/OL].Burns Trauma,2022,10:tkac013[2023-06-02].https://pubmed.ncbi.nlm.nih.gov/35547861/.DOI: 10.1093/burnst/tkac013.
    [9]
    SyedF,SinghS,BayatA.Superior effect of combination vs. single steroid therapy in keloid disease: a comparative in vitro analysis of glucocorticoids[J].Wound Repair Regen,2013,21(1):88-102.DOI: 10.1111/j.1524-475X.2012.00862.x.
    [10]
    RutkowskiD,SyedF,MatthewsLC,et al.An abnormality in glucocorticoid receptor expression differentiates steroid responders from nonresponders in keloid disease[J].Br J Dermatol,2015,173(3):690-700.DOI: 10.1111/bjd.13752.
    [11]
    Ramos-RamírezP,TlibaO.Glucocorticoid receptor β (GRβ): beyond its dominant-negative function[J].Int J Mol Sci,2021,22(7):3649.DOI: 10.3390/ijms22073649.
    [12]
    YangY,LiuL,WuX,et al.CO2 fractional laser-assisted transdermal delivery of silk nanofiber carriers in a rabbit ear hypertrophic scar model[J/OL].Burns Trauma,2022,10:tkac040[2023-06-02].https://pubmed.ncbi.nlm.nih.gov/36380852/.DOI: 10.1093/burnst/tkac040.
    [13]
    PhataleV,VaipheiKK,JhaS,et al.Overcoming skin barriers through advanced transdermal drug delivery approaches[J].J Control Release,2022,351:361-380.DOI: 10.1016/j.jconrel.2022.09.025.
    [14]
    SmithJC,BooneBE,OpalenikSR,et al.Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways[J].J Invest Dermatol,2008,128(5):1298-1310.DOI: 10.1038/sj.jid.5701149.
    [15]
    YinQ,LouterJ,NiessenFB,et al.Intralesional corticosteroid administration in the treatment of keloids: a scoping review on injection methods[J].Dermatology,2023,239(3):462-477.DOI: 10.1159/000529220.
    [16]
    AndrewsJP,MarttalaJ,MacarakE,et al.Keloids: the paradigm of skin fibrosis-pathomechanisms and treatment[J].Matrix Biol,2016,51:37-46.DOI: 10.1016/j.matbio.2016.01.013.
    [17]
    XuH,ZhuZ,HuJ,et al.Downregulated cytotoxic CD8+ T-cell identifies with the NKG2A-soluble HLA-E axis as a predictive biomarker and potential therapeutic target in keloids[J].Cell Mol Immunol,2022,19(4):527-539.DOI: 10.1038/s41423-021-00834-1.
    [18]
    SartawiZ,BlackshieldsC,FaisalW.Dissolving microneedles: applications and growing therapeutic potential[J].J Control Release,2022,348:186-205.DOI: 10.1016/j.jconrel.2022.05.045.
    [19]
    KohE,FreedmanBR,RamazaniF,et al.Controlled delivery of corticosteroids using tunable tough adhesives[J].Adv Healthc Mater,2023,12(3):e2201000.DOI: 10.1002/adhm.202201000.
    [20]
    TanC,TanWD,SrivastavaR,et al.Dissolving triamcinolone-embedded microneedles for the treatment of keloids: a single-blinded intra-individual controlled clinical trial[J].Dermatol Ther (Heidelb),2019,9(3):601-611.DOI: 10.1007/s13555-019-00316-3.
    [21]
    YangY,XiaL,NingX,et al.Enhanced drug permeation into human keloid tissues by sonophoresis-assisted microneedling[J].SLAS Technol,2021,26(6):660-666.DOI: 10.1177/24726303211024568.
    [22]
    TheocharidisG,ThomasBE,SarkarD,et al.Single cell transcriptomic landscape of diabetic foot ulcers[J].Nat Commun,2022,13(1):181.DOI: 10.1038/s41467-021-27801-8.
    [23]
    刘欣健,崔正军,张树堂,等.曲安奈德联合5-氟尿嘧啶与单独曲安奈德治疗瘢痕疙瘩效果的荟萃分析[J].中华烧伤杂志,2020,36(12):1191-1198.DOI: 10.3760/cma.j.cn501120-20190930-00390.
    [24]
    LaRangerR,Karimpour-FardA,CostaC,et al.Analysis of keloid response to 5-fluorouracil treatment and long-term prevention of keloid recurrence[J].Plast Reconstr Surg,2019,143(2):490-494.DOI: 10.1097/PRS.0000000000005257.
    [25]
    中国整形美容协会瘢痕医学分会.瘢痕早期治疗全国专家共识(2020版)[J].中华烧伤杂志,2021,37(2):113-125.DOI: 10.3760/cma.j.cn501120-20200609-00300.
    [26]
    YuanB,UptonZ,LeavesleyD,et al.Vascular and collagen target: a rational approach to hypertrophic scar management[J].Adv Wound Care (New Rochelle),2023,12(1):38-55.DOI: 10.1089/wound.2020.1348.
    [27]
    OgawaR,AkitaS,AkaishiS,et al.Diagnosis and treatment of keloids and hypertrophic scars-Japan Scar Workshop consensus document 2018[J/OL].Burns Trauma,2019,7:39[2023-06-02].https://pubmed.ncbi.nlm.nih.gov/31890718/.DOI: 10.1186/s41038-019-0175-y.
    [28]
    WenandeE,AndersonRR,HaedersdalM.Fundamentals of fractional laser-assisted drug delivery: an in-depth guide to experimental methodology and data interpretation[J].Adv Drug Deliv Rev,2020,153:169-184.DOI: 10.1016/j.addr.2019.10.003.
    [29]
    光电技术治疗皮肤创伤性瘢痕专家共识(2018版)编写组.光电技术治疗皮肤创伤性瘢痕专家共识(2018版)[J].中华烧伤杂志,2018,34(9):593-597.DOI: 10.3760/cma.j.issn.1009-2587.2018.09.007.
    [30]
    CavaliéM,SillardL,MontaudiéH,et al.Treatment of keloids with laser-assisted topical steroid delivery: a retrospective study of 23 cases[J].Dermatol Ther,2015,28(2):74-78.DOI: 10.1111/dth.12187.
    [31]
    TawaranurakN,PliensiriP,TawaranurakK.Combination of fractional carbon dioxide laser and topical triamcinolone vs intralesional triamcinolone for keloid treatment: a randomised clinical trial[J].Int Wound J,2022,19(7):1729-1735.DOI: 10.1111/iwj.13775.
    [32]
    HuangH,WangW.Molecular mechanisms of glucocorticoid resistance[J].Eur J Clin Invest,2023,53(2):e13901.DOI: 10.1111/eci.13901.
    [33]
    QuaxRA,ManenschijnL,KoperJW,et al.Glucocorticoid sensitivity in health and disease[J].Nat Rev Endocrinol,2013,9(11):670-686.DOI: 10.1038/nrendo.2013.183.
    [34]
    LiJ,Hlavka-ZhangJ,ShrimpJH,et al.PRC2 inhibitors overcome glucocorticoid resistance driven by NSD2 mutation in pediatric acute lymphoblastic leukemia[J].Cancer Discov,2022,12(1):186-203.DOI: 10.1158/2159-8290.CD-20-1771.
    [35]
    LiLB,LeungDY,MartinRJ,et al.Inhibition of histone deacetylase 2 expression by elevated glucocorticoid receptor beta in steroid-resistant asthma[J].Am J Respir Crit Care Med,2010,182(7):877-883.DOI: 10.1164/rccm.201001-0015OC.
    [36]
    XavierAM,AnunciatoAK,RosenstockTR,et al.Gene expression control by glucocorticoid receptors during innate immune responses[J].Front Endocrinol (Lausanne),2016,7:31.DOI: 10.3389/fendo.2016.00031.
    [37]
    SevillaLM,Jiménez-PanizoA,Alegre-MartíA,et al.Glucocorticoid resistance: interference between the glucocorticoid receptor and the MAPK signalling pathways[J].Int J Mol Sci,2021,22(18):10049.DOI: 10.3390/ijms221810049.
    [38]
    ZhuH,LiJ,LiY,et al.Glucocorticoid counteracts cellular mechanoresponses by LINC01569-dependent gluco-corticoid receptor-mediated mRNA decay[J].Sci Adv,2021,7(9):eabd9923.DOI: 10.1126/sciadv.abd9923.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (461) PDF downloads(67) Cited by()
    Proportional views
    Related

    Copyright © Chinese Journal of Burns京ICP备07035254号-14

    E-mail：shaoshangzazhi@163.com

    Website：https://zhsszz.xml-journal.net/

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return